Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 38

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 SARS cristina antiviral bats proteins cases antibody hcov-nl63 hong ACE2 remulus sars‐cov cristina dragomirescu recovered apoptosis
2 severe anca development civets accessory workers antibodies 229E kong s proteins case presentation model sabina avoidance family
3 acute daniela drugs bat protein southern patients human hong kong s protein sorin macaques marinescu corticosteroids coronaviridae
4 respiratory alina middle palm 8b measures recombinant hcovs isolates entry pițigoi tissue national perceptions members
5 syndrome alexandra east civet sars-cov china samples hcov-hku1 february receptor cristina popescu ferrets dalila respondents family coronaviridae
6 coronavirus mihaela mers-cov sl-covs structural proteins 2002 days coronaviruses scovs binding eliza manea exponential ilinca actions induce
7 acute respiratory syndrome raluca inhibitors sars-like orfs control serum OC43 guangzhou residues mădălina merișescu alveolar emilia discriminatory perspective
8 disease streinu-cercel coronaviruses reservoir cellular southern china sera human coronaviruses province receptor-binding adriana hristea exponential model luminița infectivity coronavirus family
9 virus adrian sars-cov-2 horseshoe structural november detected hcov-229e guangdong 1A9 camelia pneumocytes marincu % great
10 sars-cov popescu middle east respiratory syndrome coronavirus wildlife nf-κb 774 immunoglobulin NL63 singapore mab anuța bilașco dose‐response mărdărescu patients 3cl(pro
11 outbreak benea effective reservoirs 9b countries cross-reactivity hcov amoy sars-cov endis macaca fascicularis pneumoniae ribavirin effect
12 caused aramă experimental sars-like coronaviruses accessory proteins man nucleocapsid hcov-oc43 hotel angiotensin-converting hepatitis macaca tiberiu asymptomatic origins
13 agent cătălin MERS intermediate expression healthcare polymerase tract beijing mab 1a9 vlad diffuse bacruban pain system
14 identified HIV drug investigation cells july monoclonal translated common subunit rafila hybridization nițescu measured 12
15 studies elena mechanisms masked activity healthcare workers RVV-S HKU1 summary enzyme clostridium sars‐cov infection stangaciu emotional children
16 infected victoria vaccines natural activation organization NT infect index domain moroti picture varicella combined p38
17 viruses violeta pathogenic phylogenetic envelope world health organization assay group early protein giubelan ultrastructural resistance receptor-related publications
18 viral carmen anti-sars hosts 8a weeks onset acid variant sars-associated virus gavriliu cynomolgus macaques sorina confidence interval attempts
19 including monica targets sarsr-covs membrane hospital healthy tree distance diverse georgeta fascicularis manea immune-related age
20 infection cătălin tilișcan anti-sars drugs palm civets n protein 2003 % spike protein sequence flu S1 case series coronavirus-infected aspects admission glycoprotein‐specific
21 worldwide tilișcan compounds natural reservoir encodes ’s responses PM comparisons users pediatric monoclonal antibody ovidiu pneumomediastinum sars-cov 3cl(pro
22 2003 roxana respiratory rhinolophus length obstetrical reaction previously globally material holban organs beatrice receiving scov.
23 newly săndulescu review interspecies kinase respiratory illness detect amino acid clustered receptor-binding domain stoian cynomolgus ceaușu chest pain growth factors
24 human HCV recently chinese sars-cov proteins care presence abs originating SP-10 favorable damage olimpia objective respiratory system
25 clinical viorica humans restaurant 8ab probable assays coronaviruses 229e sequences s-protein romanian electron codrina propensity developments
26 associated with irina replication natural reservoirs nucleocapsid reported vγ9vδ2 tcid50/ml spread D1128A ramona-alexandra estimated predescu discrimination slcov
27 causative orfanu emergence interspecies transmission 6 postulates enzyme-linked A162 suggests authorized stoica coronavirus-infected cells podani score J.
28 study simona potential sarsr-cov 3a died immunized poorly vietnam online version popoiu cellular tropism corina-daniela perceived growth
29 molecular maria antiviral drugs sars-covs 30 appeared tested LP case lines cornel 436 mariana ECG med
30 developed mihai SCV sars-related UPR health serum samples upr-activating taiwan wild-type șchiopu logs gram-negative interval reasons
31 pneumonia alina orfanu insights animal functional transmission igg variation end site corina sets emanoil confidence coronaviridae family
32 findings andrei approved animals frames people nasopharyngeal coronavirus genetically version bacterial epithelial lăzureanu rnai wiley‐liss
33 sars coronavirus case middle east respiratory syndrome live down-regulated world antigens observed contact sars-cov s protein cherciu data sets gram-positive cocci attitudes actin
34 unknown remulus catană COVID-19 horseshoe bats 7a epidemic vaccine sequence relationship inhibited dumitru in‐situ patricia contagious member
35 animal oana săndulescu potent markets cycle globe neutralizing pathogenic interpretation region ducu pooled george 24 sars‐cov
36 RNA anca leuștean infections species reading center for disease control persons spike 2003 spike protein magda hyaline regimen profiles necrosis
37 pathogenesis laurențiu century china cytoplasm health care workers demonstrated amino hanoi mabs apostolescu diffuse alveolar damage corneliu genes scov
38 2004 romania coronavirus origin activated 8,096 sensitivity assumed orf s2 subunit liver sarscov stăncescu showed show
39 cov catană emerging human sars-cov n personal onset of hcov oc43 visited exert meningitis sporadic differential diagnosis permanently temporal
40 lung patients hcov infections genomic sequence hypothetical staff immunoassay occur 21 escape 2a/ribavirin lungs general population facing virol
41 sars-associated coronavirus clinical low reservoir(s 3b successfully cov infection productively thought S2 A37 culture magirescu ethical observation
42 methods adina HTCC genetics vero quarantine exposed clique housing blocked A70 comparable virological CXR inducing
43 rapid ana variety traded factors strict memory VR-74 cent angiotensin-converting enzyme 2 A75 animal coronaviruses infections suggestive devoid
44 information olga design pressure viewpoint illness aspirates phylogenetic tree clade counterpart A77 examination apostolescu inconclusive plan
45 mortality infection advances led properties human metapneumovirus sars-specific produced 45 viral entry A79 beta‐poisson rădulescu electrocardiography JNK
46 public abagiu 2019 horseshoe bat activate implementation nasopharyngeal aspirates 1960s phylogenetic comparisons markedly A87 diagnosed experience hypoxia/hyperoxia-related AIDS
47 resulted mona helicase wildlife animals experiments regarded SARS UK signatures D1128 A91 distinct vitamin d deficiency extended zoonotic coronavirus
48 evidence ioana suitable masked palm civet AVLQSGFR economy probable human coronavirus hku1 27 altering A94 surface A102 high‐resolution variables
49 isolation luca ifns intermediate hosts signal research groups 2 topology history separated A95 data A112 microarrays efficacious
50 coronaviruses albu 21(st scientific synthesis hospital b role plasma meticulous cell lines A97 infection A63 downregulated exceed